New Jersey boy, 5, diagnosed with high-risk cancer as family raises $120K for treatment support HAWORTH, N.J. — A 5-year-old boy from Haworth is facing a grueling 18-month treatment plan after being diagnosed with high-risk neuroblastoma, a rare and aggressive form of childhood cancer, according to his…
Injured grey seal pup rescued in Atlantic City, receiving treatment at Marine Mammal Stranding Center
Former Owner of Chicago Health Care Company Sentenced to a Year in Federal Prison for Billing Medicare for Non-Existent Treatment
RECOVERY CENTERS OF AMERICA AT ST. CHARLES AND SOUTH ELGIN ANNOUNCE TWO NEW SPECIALIZED TREATMENT PROGRAMS, “DISCOVER” AND “BALANCE” DURING MAY MENTAL HEALTH AWARENESS MONTH
Wyatt Detention Center to Provide Opioid Use Disorder Treatment to Detainees in Treatment Prior to Detention
3 Found Guilty of Participating in Scheme to Submit Millions of Dollars in Fraudulent Bills for Substance Abuse Treatment for Teens
Bausch + Lomb Presents Data from Second Pivotal Phase 3 Trial of Investigational Treatment NOV03 (Perfluorohexyloctane) at the Association for Research in Vision and Ophthalmology Annual Meeting
Bausch + Lomb Presents Data from First Pivotal Phase 3 Trial of Investigational Treatment NOV03 (Perfluorohexyloctane) at the American Society of Cataract and Refractive Surgery Annual Meeting
John Theurer Cancer Center Treats First Patient in U.S. with Investigational New Treatment for Brain Cancer
Bausch + Lomb and Clearside Biomedical Announce the U.S. Commercial Launch of XIPERE® (Triamcinolone Acetonide Injectable Suspension) For Suprachoroidal Use for the Treatment of Macular Edema Associated with Uveitis
Clearbrook Treatment Centers And Andrew Brown’s Drug Store Agree To Pay The United States Civil Penalties For Violations Of The Controlled Substances Act
Federal Court Rules in Favor of the Justice Department in Lawsuit Against City of Troy, Michigan For Restrictions on Places of Worship and Treatment of Muslim Religious Group
Recovery Centers of America at St. Charles Designated as a Blue Distinction® Center for Substance Use Treatment and Recovery
United States Files Enforcement Action to Stop Deceptive Marketing of Herbal Tea Product Advertised as Covid-19 Treatment